Literature DB >> 12720599

Pharmacotherapy for pain in rheumatologic conditions: the neuropathic component.

Keri L Fakata1, Arthur G Lipman.   

Abstract

Nociceptive and neuropathic types of pain occur in rheumatologic conditions. Most clinicians are familiar with the former, but many are not aware of the prevalence of the latter. The literature reports numerous examples of the occurrence of rheumatologic neuropathic pain, but little has been published on its management. In this article, neuropathic and nociceptive pain in rheumatologic conditions are differentiated and treatment recommendations are discussed. Common rheumatologic conditions and their pathophysiology in relation to pain mechanisms also are described. Pharmacotherapeutic recommendations for the treatment of both types of pain in the common rheumatologic conditions are presented.

Entities:  

Mesh:

Year:  2003        PMID: 12720599     DOI: 10.1007/s11916-003-0073-6

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  43 in total

1.  Altered levels of soluble adhesion molecules in patients with rheumatoid arthritis complicated by peripheral neuropathy.

Authors:  MiedanyYasserM El; Samia Ashour; Hossam Moustafa; Ihab Ahmed
Journal:  J Rheumatol       Date:  2002-01       Impact factor: 4.666

Review 2.  Recognizing peripheral neuropathy. How to read the clues to an underlying cause.

Authors:  J C Morgenlander
Journal:  Postgrad Med       Date:  1997-09       Impact factor: 3.840

3.  Opioid pseudoaddiction--an iatrogenic syndrome.

Authors:  D E Weissman; J D Haddox
Journal:  Pain       Date:  1989-03       Impact factor: 6.961

4.  Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis.

Authors:  J L Goldstein; P Correa; W W Zhao; A M Burr; R C Hubbard; K M Verburg; G S Geis
Journal:  Am J Gastroenterol       Date:  2001-04       Impact factor: 10.864

5.  Lightning pains in ankylosing spondylitis: response to carbamazepine.

Authors:  C de Andrés; S Giménez-Roldán
Journal:  Arch Neurol       Date:  1983-11

6.  Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.

Authors:  F E Silverstein; G Faich; J L Goldstein; L S Simon; T Pincus; A Whelton; R Makuch; G Eisen; N M Agrawal; W F Stenson; A M Burr; W W Zhao; J D Kent; J B Lefkowith; K M Verburg; G S Geis
Journal:  JAMA       Date:  2000-09-13       Impact factor: 56.272

Review 7.  Chronic neuropathic pain: mechanisms and treatment.

Authors:  N Attal
Journal:  Clin J Pain       Date:  2000-09       Impact factor: 3.442

8.  Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety and Efficacy Large-scale Evaluation of COX-inhibiting Therapies (SELECT) trial in osteoarthritis.

Authors:  J Dequeker; C Hawkey; A Kahan; K Steinbrück; C Alegre; E Baumelou; B Bégaud; H Isomäki; G Littlejohn; J Mau; S Papazoglou
Journal:  Br J Rheumatol       Date:  1998-09

Review 9.  Mechanisms of pain in arthritis.

Authors:  Hans-Georg Schaible; Andrea Ebersberger; Gisela Segond Von Banchet
Journal:  Ann N Y Acad Sci       Date:  2002-06       Impact factor: 5.691

10.  Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy.

Authors:  Y Harati; C Gooch; M Swenson; S Edelman; D Greene; P Raskin; P Donofrio; D Cornblath; R Sachdeo; C O Siu; M Kamin
Journal:  Neurology       Date:  1998-06       Impact factor: 9.910

View more
  1 in total

1.  Neuropathic pain: is it an underestimated symptom in systemic sclerosis?

Authors:  Nihan Cuzdan; Ipek Turk; Tunay Sarpel; Eren Erken; Zeliha Nazan Alparslan
Journal:  Clin Rheumatol       Date:  2018-04-24       Impact factor: 2.980

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.